1. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
- Author
-
Ponikowski, Piotr, Kirwan, Bridget-Anne, Anker, Stefan D, McDonagh, Theresa, Dorobantu, Maria, Drozdz, Jarosław, Fabien, Vincent, Filippatos, Gerasimos, Göhring, Udo Michael, Keren, Andre, Khintibidze, Irakli, Kragten, Hans, Martinez, Felipe A, Metra, Marco, Milicic, Davor, Nicolau, José C, Ohlsson, Marcus, Parkhomenko, Alexander, Pascual-Figal, Domingo A, Ruschitzka, Frank, Sim, David, Skouri, Hadi, van der Meer, Peter, Lewis, Basil S, Comin-Colet, Josep, von Haehling, Stephan, Cohen-Solal, Alain, Danchin, Nicolas, Doehner, Wolfram, Dargie, Henry J, Motro, Michael, Butler, Javed, Friede, Tim, Jensen, Klaus H, Pocock, Stuart, Jankowska, Ewa A, Azize, G, Fernandez, A, Zapata, GO, Garcia Pacho, P, Glenny, A, Ferre Pacora, F, Parody, ML, Bono, J, Beltrano, C, Hershson, A, Vita, N, Luquez, HA, Cestari, HG, Fernandez, H, Prado, A, Berli, M, García Durán, R, Thierer, J, Diez, M, Lobo Marquez, L, Borelli, RR, Hominal, MÁ, Metra, M, Ameri, P, Agostoni, P, Salvioni, A, Fattore, L, Gronda, E, Ghio, S, Turrini, F, Uguccioni, M, Di Biase, M, Piepoli, M, Savonitto, S, Mortara, A, Terrosu, P, Fucili, A, Boriani, G, Midi, P, Passamonti, E, Cosmi, F, van der Meer, P, Van Bergen, P, van de Wetering, M, Al-Windy, NYY, Tanis, W, Meijs, M, Groutars, RGEJ, The, HKS, Kietselaer, B, van Kesteren, HAM, Beelen, DPW, Heymeriks, J, Van de Wal, R, Schaap, J, Emans, M, Westendorp, P, Nierop, PR, Nijmeijer, R, Manintveld, OC, Dorobantu, M, Darabantiu, DA, Zdrenghea, D, Toader, DM, Petrescu, L, Militaru, C, Crisu, D, Tomescu, MC, Stanciulescu, G, Rodica Dan, A, Iosipescu, LC, Serban, DL, Drozdz, J, Szachniewicz, J, Bronisz, M, Tycińska, A, Wozakowska-Kaplon, B, Mirek-Bryniarska, E, Gruchała, M, Nessler, J, Straburzyńska-Migaj, E, Mizia-Stec, K, Szelemej, R, Gil, R, Gąsior, M, Gotsman, I, Halabi, M, Shochat, M, Shechter, M, Witzling, V, Zukermann, R, Arbel, Y, Flugelman, M, Ben-Gal, T, Zvi, V, Kinany, W, Weinstein, JM, Atar, S, Goland, S, Milicic, D, Horvat, D, Tušek, S, Udovicic, M, Šutalo, K, Samodol, A, Pesek, K, Artuković, M, Ružić, A, Šikić, J, McDonagh, T, Trevelyan, J, Wong, Y-K, Gorog, D, Ray, R, Pettit, S, Sharma, S, Kabir, A, Hamdan, H, Tilling, L, Baracioli, L, Nigro Maia, L, Dutra, O, Reis, G, Pimentel Filho, P, Saraiva, JF, Kormann, A, dos Santos, FR, Bodanese, L, Almeida, D, Precoma, D, Rassi, S, Costa, F, Kabbani, S, Abdelbaki, K, Abdallah, C, Arnaout, MS, Azar, R, Chaaban, S, Raed, O, Kiwan, G, Hassouna, B, Bardaji, A, Zamorano, J, del Prado, S, Gonzalez Juanatey, JR, Ga Bosa Ojeda, FI, Gomez Bueno, M, Molina, BD, Pascual Figal, DA, Sim, D, Yeo, TJ, Loh, SY, Soon, D, Ohlsson, M, Smith, JG, Gerward, S, Khintibidze, I, Lominadze, Z, Chapidze, G, Emukhvari, N, Khabeishvili, G, Chumburidze, V, Paposhvili, K, Shaburishvili, T, Khabeishvili, G, Parhomenko, O, Kraiz, I, Koval, O, Zolotaikina, V, Malynovsky, Y, Vakaliuk, I, Rudenko, L, Tseluyko, V, and Stanislavchuk, M
- Abstract
Intravenous ferric carboxymaltose has been shown to improve symptoms and quality of life in patients with chronic heart failure and iron deficiency. We aimed to evaluate the effect of ferric carboxymaltose, compared with placebo, on outcomes in patients who were stabilised after an episode of acute heart failure.
- Published
- 2020
- Full Text
- View/download PDF